Framingham and Reynolds risk scores underrate cardiovascular disease danger for patients with rheumatoid arthritis
A study confirms that inflammation, which plays a key role in putting patients with rheumatoid arthritis at increased risk for heart disease, is not a factor in many cardiac risk assessment methods.
Study connects dilated cardiomyopathy to GATAD1 geneBone marrow stem cells improve blood function
Researchers used classical genetic tactics and current gene sequencing tools to identify a new gene that causes cardiomyopathy in a family whose members display a unique recessive form of inheritance: mutations in both copies of a gene.
Study participants received either a placebo or 100 million stem cells derived from bone marrow in their hips in a one-time injection intended to improve the function of the heart's left ventricle. Certain stem cell types were associated with the greatest improvement. View video on YouTube.Patients with hypersensitivity to metals may safely receive coronary stents
Researchers who compared outcomes after placing stents in those with and without a history of skin allergy to stent metal components found no evidence of an increased risk of heart attack, death or restenosis in study participants.
26th Annual Echocardiographic Symposium at Vail Cardiology Update 2012 Sedona
July 22-26, 2012, in Vail, Colo.
An intensive, comprehensive review emphasizes introduction of new technologies and use of echocardiographic information for patient care. The symposium stresses integration of all echocardiography techniques into the ultrasound examination. Emphasis includes new technologies, Doppler hemodynamics, tissue Doppler, diastology, transesophageal echocardiography and heart failure.
Aug. 2-5, 2012, in Sedona, Ariz.
Success With Heart Failure
Topics include guidelines to prevent and improve morbidity and mortality rates and reduce cost of care for patients with diabetes and heart disease; preoperative evaluation of CV patients undergoing noncardiac surgery; and indications, use and limitations of advanced device therapy for congestive heart failure.
Aug. 12-15, 2012, in Tahoe, Nev.
Pediatric Cardiology 2012 Board Review Course
This course, subtitled Strategies for the Evaluation and Treatment of Heart Failure in the Clinical Practice, reviews new diagnostic tools, drugs and devices and their roles in specific clinical situations. A special session on the ABIM heart failure module will be presented.
Aug. 26-31, 2012, in Dana Point, Calif.
This course covers subspecialty content important to preparation for certification and provides an unparalleled interactive learning experience. Mini-symposia address electrophysiology, statistics and epidemiology, test-taking skills, and professional development. Workshops include cardiac anatomy, pathophysiology, echocardiography and cardiac catheterization.
See all Cardiovascular Diseases Continuous Professional Development courses